MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,199,555 | +32.5% | 112,952 | +61.5% | 0.37% | +45.1% |
| Q4 2022 | $3,169,570 | -32.8% | 69,953 | +3.6% | 0.25% | -36.8% |
| Q3 2022 | $4,715,000 | -7.3% | 67,514 | -10.9% | 0.40% | -7.0% |
| Q2 2022 | $5,085,000 | +58.2% | 75,745 | +93.8% | 0.43% | +70.6% |
| Q1 2022 | $3,214,000 | -82.0% | 39,092 | -67.9% | 0.25% | -77.9% |
| Q4 2021 | $17,857,000 | +8.4% | 121,736 | +30.7% | 1.14% | +11.4% |
| Q3 2021 | $16,480,000 | +38.4% | 93,157 | +26.4% | 1.02% | +69.4% |
| Q2 2021 | $11,906,000 | +60.0% | 73,710 | +69.7% | 0.60% | +22.3% |
| Q1 2021 | $7,439,000 | – | 43,428 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |